MDM2 antagonist clinical response association with a gene expression signature in acute myeloid leukaemia

Hua Zhong, Gong Chen, Lori Jukofsky, David Geho, Sung Won Han, Fabian Birzele, Sabine Bader, Lucia Himmelein, James Cai, Zayed Albertyn, Mark Rothe, Laurent Essioux, Helmut Burtscher, Steven A. Middleton, Ruediger Rueger, Lin Chi Chen, Markus Dangl, Gwen Nichols, William E. Pierceall

Research output: Contribution to journalLetter

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)432-435
Number of pages4
JournalBritish Journal of Haematology
Volume171
Issue number3
DOIs
Publication statusPublished - 2015 Nov

Keywords

  • Acute myeloid leukaemia
  • Diagnostic algorithm
  • Gene expression signature
  • MDM2 antagonist
  • TP53

ASJC Scopus subject areas

  • Hematology

Cite this

Zhong, H., Chen, G., Jukofsky, L., Geho, D., Han, S. W., Birzele, F., Bader, S., Himmelein, L., Cai, J., Albertyn, Z., Rothe, M., Essioux, L., Burtscher, H., Middleton, S. A., Rueger, R., Chen, L. C., Dangl, M., Nichols, G., & Pierceall, W. E. (2015). MDM2 antagonist clinical response association with a gene expression signature in acute myeloid leukaemia. British Journal of Haematology, 171(3), 432-435. https://doi.org/10.1111/bjh.13411